Haro Hartounian, the senior vice president and general manager for Biopharma at NJII, discussed at ISCT 2020 how the division’s cell and gene therapy development and manufacturing center, BioCentriq, is advancing therapies and building the workforce of the future. Watch it now!
This presentation was conducted as part of the ISCT 2020 Paris Virtual Meeting http://www.isct2020.com/. To learn more about our Biopharma Division, please visit www.njii.com/biopharma. To learn more about BioCentriq, visit www.biocentriq.com.